The IMPRSSION Clinical Trial

The IMPRSSION clinical trial is a Phase 2 clinical study of an investigational antisense medicine for people living with polycythemia vera (PV), a disease of the bone marrow and blood where too many red blood cells are produced.

Study Icon

The Study arrow

Learn about how the IMPRSSION clinical trial works

Location Icon

Find a Study Site arrow

Enter your location to see all study sites near you

Disease Icon

About PV arrow

Read about PV and current treatment options.